These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 10257551)

  • 21. Guidelines on the operation of the pharmacy and therapeutics committee and formulary.
    Linkewich JA; Prevoznik SJ
    Hosp Pharm; 1979 Jan; 14(1):7-10, 13, 16-9 passim. PubMed ID: 10240149
    [No Abstract]   [Full Text] [Related]  

  • 22. Formulary management to reduce cost: P & T committee strategies.
    Roberts MJ; Summerfield MR
    Hosp Formul; 1986 Apr; 21(4):481-3, 488-92. PubMed ID: 10276289
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pricing of multiple dosage prescription medications: an analysis of the Ontario Drug Benefit Formulary.
    Lexchin J
    Health Policy; 2009 Jul; 91(2):142-7. PubMed ID: 19147251
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug usage guidelines, Part 2: Analysis of program outcome.
    Patry RA; Huber SL; Hudson HD; Godwin HN
    Hosp Formul; 1985 Jan; 20(1):57-60. PubMed ID: 10269762
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Total formulary review--the easy way.
    Chase K; Meyer JD; Kelly WN
    Hosp Pharm; 1984 Mar; 19(3):159-62. PubMed ID: 10265845
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A method for familiarizing nurses with the hospital formulary.
    Mansur JM; Ifshin SL; Abramowitz PW
    Hosp Pharm; 1983 Nov; 18(11):582-3, 587. PubMed ID: 10315474
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Restricted cephalosporin use in teaching hospitals.
    Johnson PN; Jeffrey LP
    Am J Hosp Pharm; 1981 Apr; 38(4):513-7. PubMed ID: 7282677
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A survey of Pharmacy and Therapeutic committees across Canada: scope and responsibilities.
    Mittmann N; Knowles S
    Can J Clin Pharmacol; 2009; 16(1):e171-7. PubMed ID: 19242000
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Creating an ostomy product formulary.
    Turnbull G
    Ostomy Wound Manage; 2002 Mar; 48(3):14-5. PubMed ID: 11968889
    [No Abstract]   [Full Text] [Related]  

  • 30. The truth about hospital formularies: survey shows many myths still exist 15 years later.
    Pa Nurse; 2005 Jun; 60(3):30, 33. PubMed ID: 16032986
    [No Abstract]   [Full Text] [Related]  

  • 31. ASHP guidelines for hospital formularies.
    Am J Hosp Pharm; 1978 Mar; 35(3):326-8. PubMed ID: 626216
    [No Abstract]   [Full Text] [Related]  

  • 32. A comparison of Canadian general pediatric dosing publications.
    Dayneka N
    Can J Clin Pharmacol; 2003; 10(3):107-10. PubMed ID: 14506508
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Dilemmas of the pharmacist, 7th edition of Hungarian National Formulary in practice].
    Pál S
    Acta Pharm Hung; 2005; 75(4):199-203. PubMed ID: 16711397
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ASHP technical assistance bulletin on hospital formularies.
    Am J Hosp Pharm; 1985 Feb; 42(2):375-7. PubMed ID: 3976687
    [No Abstract]   [Full Text] [Related]  

  • 35. Pharmaceuticals issue brief: managed care drug formularies: year end report-2003.
    MacEachern L
    Issue Brief Health Policy Track Serv; 2003 Dec; ():1-8. PubMed ID: 14969259
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Perspectives on the hospital formulary.
    Hoffmann RP
    Hosp Pharm; 1984 May; 19(5):359-61, 364. PubMed ID: 10266244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changing physician prescribing habits through a cost-effective first generation cephalosporin formulary.
    Cramer R; Wright C
    Hosp Pharm; 1989 Jan; 24(1):33-8. PubMed ID: 10312858
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Formulary management at a tertiary-care facility: P&T committee interview.
    Lucas RV; Abramowitz PW
    Hosp Formul; 1988 Feb; 23(2):162-8, 172-3. PubMed ID: 10286021
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of health-related quality of life information in managed care formulary decision-making.
    Wu WK; Sause RB; Zacker C
    Res Social Adm Pharm; 2005 Dec; 1(4):579-98. PubMed ID: 17138497
    [TBL] [Abstract][Full Text] [Related]  

  • 40. P & T Committee interview: communication and education contribute to an effective formulary system.
    Hinthorn D; Godwin H
    Hosp Formul; 1989 May; 24(5):281-4, 286-7. PubMed ID: 10292977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.